Structural and functional interactions between six-transmembrane μ-opioid receptors and β2-adrenoreceptors modulate opioid signaling

Autor: Marino Convertino, Oleg Kambur, Nikolay V. Dokholyan, Chi T. Viet, Eija Kalso, Luda Diatchenko, Jeffrey S. Wieskopf, Laura S. Stone, Pinkal Patel, Brian L. Schmidt, Jeffrey S. Mogil, William Maixner, Alexander Samoshkin, Jaclyn Marcovitz
Přispěvatelé: Medicum, Department of Pharmacology, Clinicum, Eija Kalso / Principal Investigator, Department of Diagnostics and Therapeutics, Anestesiologian yksikkö
Jazyk: angličtina
Rok vydání: 2015
Předmět:
0301 basic medicine
Models
Molecular

Molecular Conformation
Receptors
Opioid
mu

Gene Expression
Ligands
BETA(2)-ADRENERGIC RECEPTOR
Mice
MOR-1 SPLICE VARIANTS
GABA(B) RECEPTORS
0302 clinical medicine
Receptor
BETA-2-ADRENERGIC RECEPTOR
Neurons
Multidisciplinary
Transmembrane protein
3. Good health
Cell biology
Analgesics
Opioid

Hyperalgesia
medicine.symptom
Signal transduction
CHRONIC PAIN
medicine.drug
Protein Binding
Signal Transduction
Gene isoform
medicine.medical_specialty
Cell signaling
Adrenergic receptor
Biology
Article
03 medical and health sciences
Structure-Activity Relationship
Internal medicine
medicine
Animals
Humans
DISCRETE MOLECULAR-DYNAMICS
THERAPEUTIC TARGET
MORPHINE-TOLERANCE
3126 Surgery
anesthesiology
intensive care
radiology

RHEUMATOID-ARTHRITIS
030104 developmental biology
Endocrinology
Opioid
RAT
Calcium
Ganglia
Receptors
Adrenergic
beta-2

030217 neurology & neurosurgery
Zdroj: Scientific Reports
ISSN: 2045-2322
Popis: The primary molecular target for clinically used opioids is the μ-opioid receptor (MOR). Besides the major seven-transmembrane (7TM) receptors, the MOR gene codes for alternatively spliced six-transmembrane (6TM) isoforms, the biological and clinical significance of which remains unclear. Here, we show that the otherwise exclusively intracellular localized 6TM-MOR translocates to the plasma membrane upon coexpression with β2-adrenergic receptors (β2-ARs) through an interaction with the fifth and sixth helices of β2-AR. Coexpression of the two receptors in BE(2)-C neuroblastoma cells potentiates calcium responses to a 6TM-MOR ligand and this calcium response is completely blocked by a selective β2-antagonist in BE(2)-C cells and in trigeminal and dorsal root ganglia. Co-administration of 6TM-MOR and β2-AR ligands leads to substantial analgesic synergy and completely reverses opioid-induced hyperalgesia in rodent behavioral models. Together, our results provide evidence that the heterodimerization of 6TM-MOR with β2-AR underlies a molecular mechanism for 6TM cellular signaling, presenting a unique functional responses to opioids. This signaling pathway may contribute to the hyperalgesic effects of opioids that can be efficiently blocked by β2-AR antagonists, providing a new avenue for opioid therapy.
Databáze: OpenAIRE